Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Breast Cancer
Interventions: DRUG: [18F]FMISO PET/MRI imaging
Sponsor: University of Alabama at Birmingham